A Preliminary Study of Different Treatment Strategies for Anxious Depression.

Yun WangXiaohua LiuDai-Hui PengYan WuYun-Ai SuJia XuXiancang MaYi LiJianfei ShiXiaojing ChengHan RongYi-Ru Fang

Published in: Neuropsychiatric disease and treatment (2022)

This preliminary trial suggests that all four interventions (mirtazapine/SNRIs, mirtazapine/SNRIs+CBT, mirtazapine+SNRIs, or mirtazapine+SNRIs+physical therapies) achieved similar response and remission rates in patients with anxiety/somatic subtype MDD. The safety profile was manageable.

Keyphrases

physical activity
sleep quality
depressive symptoms
major depressive disorder
phase iii
disease activity
rheumatoid arthritis
phase ii
copy number
dna methylation
systemic lupus erythematosus
gene expression
bipolar disorder
open label